Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 291 Carcinoma, Non-Small-Cell Lung 222 Neoplasms 193 Prostatic Neoplasms 158 Multiple Myeloma 138 Neoplasm Metastasis 115 Melanoma 110 Colorectal Neoplasms 107 Leukemia, Myeloid, Acute 103 Lymphoma 97 Lung Neoplasms 94 Ovarian Neoplasms 84 Squamous Cell Carcinoma of Head and Neck 75 Lymphoma, Non-Hodgkin 73 Leukemia, Lymphocytic, Chronic, B-Cell 70 Pancreatic Neoplasms 64 Triple Negative Breast Neoplasms 62 Myelodysplastic Syndromes 62 Parkinson Disease 4, Autosomal Dominant Lewy Body 59 Hematologic Neoplasms 59 Head and Neck Neoplasms 59 Recurrence 56 Glioblastoma 55 Leukemia 53 Precursor Cell Lymphoblastic Leukemia-Lymphoma 52 Sarcoma 49 Brain Neoplasms 49 Lymphoma, Large B-Cell, Diffuse 47 Carcinoma, Hepatocellular 47 Lymphoma, Follicular 45

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Warts × 1 year × Clear all

NCT05087849 2025-10-02

Intralesional HPV Vaccine for Condylomata

University of California, San Francisco

Phase 1/2 Completed

2 enrolled 7 charts

Condylomata Acuminata, Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡